STACEY SIESE: Open Payments
NPI 1669092367 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$683 in 35 payments from 11 companies in 2025. Trend: 2023 $486 · 2024 $698 · 2025 $683
Food & beverage: $683
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $125 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $82 |
| AstraZeneca Pharmaceuticals LP | 4 | $77 |
| Lilly USA, LLC | 4 | $73 |
| PFIZER INC. | 3 | $71 |
| Kowa Pharmaceuticals America, Inc. | 4 | $70 |
| ABBVIE INC. | 3 | $60 |
| Exact Sciences Corporation | 3 | $46 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Abbott Laboratories | 1 | $23 |
Products named: Kerendia, ZORYVE, Wegovy, MOUNJARO, ELIQUIS, UBRELVY, FARXIGA, SHINGRIX.
Industry payments across NV — which companies pay providers there.
